Developing world would boost cancer drug growth

Font Size -

Associated Press

Posted online: Thursday , May 15, 2008 at 02:23:40

Now, trick your brain with a virtual rea...Now, trick your brain with a virtual rea...Happiness 'can cut breast cancer risk by...A stroll on the beach ‘may damage your l...

Washington, May 15: global market for cancer drugs will grow twice as fast as that for all other pharmaceuticals as the developing world spends more on health care, a new report says.

China, Brazil, Russia and other emerging countries are becoming bigger customers for pharmaceuticals as they invest more in treating and diagnosing cancer, according to a report issued today by IMS Health.

The health care research firm expects pharmaceutical spending in countries such as India, Mexico and Turkey to grow by 12 to 13 per cent over the next 15 years, compared with single-digit growth for more developed nations.

Cancer drug spending is expected to grow between 12 and 15 per cent annually through 2012 to USD 75 to 80 billion, according the report.

The overall drug market is expected to grow at 6.4 per cent.

Feeding that demand are the multibillion-dollar research and development budgets of firms like Genentech Inc, Amgen Inc and Novartis AG.

“Oncology is the top of the bill when it comes to new products in development,” said Titus Pattel, a vice president with IMS. “Oncology R&D dwarfs all other research efforts within these organizations.” Cancer drug sales are expected to reach USD 48 billion this year, led by Genentech’s breast cancer drug Herceptin, Novartis’ leukemia drug Gleevec and other blockbusters.

But the market is not immune to a slowdown. Expiring patents on older cancer drugs and efforts to tighten health care spending could limit future growth, according to IMS.

Post Comments

Name*		Email ID*
Subject*		Country*
Message*	Characters remaining

TERMS OF USE: The views represented here are not neccesarily endorsed by www.expressindia.com and its allied websites. All messages will be moderated and no message that has inflammatory, abusive, derogatory language or any language deemed unfit for publication by the editor will be displayed. Though it will be endeavoured that as many messages as possible be displayed, there will be time lag between the submission and publication of the messages. The website reserves the right to publish or reject any message.

I agree to the terms of use.